Delivery Order SPE2DB20D3103-SPE2DB25FP9R2
- Not listed
- The Defense Logistics Agency awarded a $22,459.46 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,178.39 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $9,432.60 delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of April 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $3,405.18 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction, reflecting the contractor's established capability to meet federal...
- The Defense Logistics Agency awarded a $3,254.50 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a $57,770.08 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $37,333.81 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $7,902.75 under a firm fixed-price contract. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.02 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Multaq 400 mg tablets in a 60-count package. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of August 8, 2025. As a child contract under a larger vehicle,...
- The Defense Logistics Agency awarded a $8,741.97 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9R2Delivery Order
The Defense Logistics Agency awarded a $3.45K delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. The contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99B vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/20/25 |